PlainRecalls
FDA Devices Moderate Class II Ongoing

VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2

Reported: August 21, 2024 Initiated: July 3, 2024 #Z-2580-2024

Product Description

VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2

Reason for Recall

It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.

Details

Units Affected
18,467 units
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Columbia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Sweden, United Kingdom.
Location
Rochester, NY

Frequently Asked Questions

What product was recalled?
VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2. Recalled by Ortho-Clinical Diagnostics, Inc.. Units affected: 18,467 units.
Why was this product recalled?
It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 21, 2024. Severity: Moderate. Recall number: Z-2580-2024.